Long-term obesity
1 paper2 findings
- Humans1
Associations
2IL-6
upin humans1
1 study
IL-6
upin humans1
Long-term obesity is associated with IL-6 in humans (Log IL-6: 0.69 vs 1.03 vs 0.99; Cohen f = 0.53 (95% CI, 0.41–0.62)).
“IL-6 (log, 0.69 [0.5] vs 1.03 [0.4] vs 0.99 [0.4]; P < .001; f = 0.53 [95% CI, 0.41-0.62])”
HumansHealthy BMI across life versus persistent obesity since adolescence versus persistent obesity since childhoodn = 205
Long-Term Obesity and Biological Aging in Young Adults
JAMA network open1 Jul 2025
C-reactive protein
upin humans1
1 study
C-reactive protein
upin humans1
Long-term obesity is associated with C-reactive protein in humans (1.69 vs 3.67 vs 4.24 mg/L; Cohen f = 0.57 (95% CI, 0.44–0.70)).
“including mean (SD) hs-CRP (1.69 [2.1] vs 3.67 vs 4.24 [2.4] mg/L; P < .001; f = 0.57 [95% CI, 0.44-0.70])”
HumansHealthy BMI across life versus persistent obesity since adolescence versus persistent obesity since childhoodn = 205
Long-Term Obesity and Biological Aging in Young Adults
JAMA network open1 Jul 2025
Latest
9 in 12 monthsEndocrinology, Diabetes & Metabolism
Liraglutide in Adults With Obesity: A Multicentre, Single-Arm, Post-Marketing Surveillance Study in Taiwan
Non-randomised trial in 259 peopleLiraglutide
Obesity
Joint Effects of Long-Term Obesity and Genetic Susceptibility on Sex-Specific Brain Aging
Cohort study of 35,092 peopleObesity
Indian Journal of Pharmacology
Pharmacological management of obesity: Current landscape and emerging therapies
ReviewObesity
The American Journal of Clinical Nutrition
Major dietary protein sources during pregnancy and obesity risk in mothers and offspring: A prospective cohort study
Cohort study of 59,791 peopleObesity
GeroScience
The impact of cumulative obesity and genetic susceptibility on biological aging in Chinese older adults
Cohort study of 687 peoplePopulations
PsyArXiv
Cognitive performance in young and middle-aged adults with obesity: a systematic literature review
Preprint: systematic review of observational studiesObesity
ADA Scientific Sessions 2026 Abstract
Petrelintide, a Human Amylin Analog for the Treatment of Obesity: Efficacy and Safety from the Phase 2 Trial, ZUPREME 1
Randomised trial in 485 peopleObesity